Blood Reviews
Volume 20, Issue 4 , Pages 213-226 , July 2006

Anemia in the elderly: Current understanding and emerging concepts

  • Richard Eisenstaedt

      Affiliations

    • Temple University School of Medicine, Philadelphia, PA 19140, USA
    • ,
  • Brenda W.J.H. Penninx

      Affiliations

    • Institute for Research in Extramural Medicine and Department of Psychiatry, VU University Medical Center, Amsterdam, The Netherlands
    • ,
  • Richard C. Woodman

      Affiliations

    • Ortho Biotech Clinical Affairs, Bridgewater, NJ 08807, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1 908 541 4307.

References 

  1. Nandigam V, Nandigam K, Badhe BA, Dutta TK. Is adult definition of anemia applicable to a geriatric population? Study of erythrocyte parameters in Indian geriatric inpatients. J Am Geriatr Soc. 2004;52:1589–1590
  2. Chaves PH, Xue QL, Guralnik JM, Ferrucci L, Volpato S, Fried LP. What constitutes normal hemoglobin concentration in community-dwelling disabled older women?. J Am Geriatr Soc. 2004;52:1811–1816
  3. Penninx BW, Pahor M, Cesari M, Corsi AM, Woodman RC, Bandinelli S, et al. Anemia is associated with disability and decreased physical performance and muscle strength in the elderly. J Am Geriatr Soc. 2004;52:719–724
  4. Chaves PH, Ashar B, Guralnik JM, Fried LP. Looking at the relationship between hemoglobin concentration and prevalent mobility difficulty in older women. Should the criteria currently used to define anemia in older people be reevaluated. J Am Geriatr Soc. 2002;50:1257–1264
  5. Ershler WB, Sheng S, McKelvey J, Artz AS, Denduluri N, Tecson J, et al. Serum erythropoietin and aging: a longitudinal analysis. J Am Geriatr Soc. 2005;53:1360–1365
  6. National Health and Nutrition Examination Survey. Anthropometric Reference Data, United States. 1988–1994. Available at: http://www.cdc.gov/nchs/about/major/nhanes/Anthropometric%20Measures. htm. Accessed December 5, 2005.
  7. Guralnik JM, Eisenstaedt RS, Ferrucci L, Klein HG, Woodman RC. Prevalence of anemia in persons 65 years and older in the United States: evidence for a high rate of unexplained anemia. Blood. 2004;104:2263–2268
  8. Fleming DJ, Jacques PF, Tucker KL, Massaro JM, D’Agostino RB, Wilson PW, et al. Iron status of the free-living, elderly Framingham Heart Study cohort: an iron-replete population with a high prevalence of elevated iron stores. Am J Clin Nutr. 2001;73:638–646
  9. Artz AS, Fergusson D, Drinka PJ, Gerald M, Bidenbender R, Lechich A, et al. Mechanisms of unexplained anemia in the nursing home. J Am Geriatr Soc. 2004;52:423–427
  10. Izaks GJ, Westendorp RG, Knook DL. The definition of anemia in older persons. JAMA. 1999;281:1714–1717
  11. Olivares M, Hertrampf E, Capurro MT, Wegner D. Prevalence of anemia in elderly subjects living at home: role of micronutrient deficiency and inflammation. Eur J Clin Nutr. 2000;54:834–839
  12. Inelmen EM, D’Alessio M, Gatto MR, Baggio MB, Jimenez G, Bizzotto MG, et al. Descriptive analysis of the prevalence of anemia in a randomly selected sample of elderly people living at home: some results of an Italian multicentric study. Aging (Milano). 1994;6:81–89
  13. Beutler E, West C. Hematologic differences between African-Americans and whites: the roles of iron deficiency and {alpha}-thalassemia on hemoglobin levels and MCV. Blood. 2005;106:740–745
  14. Rimon E, Levy S, Sapir A, Gelzer G, Peled R, Ergas D, et al. Diagnosis of iron deficiency anemia in the elderly by transferrin receptor-ferritin index. Arch Intern Med. 2002;162:445–449
  15. Milman N, Pedersen AN, Ovesen L, Schroll M. Iron status in 358 apparently healthy 80- year-old Danish men and women: relation to food composition and dietary and supplemental iron intake. Ann Hematol. 2004;83:423–429
  16. Smith DL. Anemia in the elderly. Am Fam Physician. 2000;62:1565–1572
  17. Rockey DC, Cello JP. Evaluation of the gastrointestinal tract in patients with iron-deficiency anemia. N Engl J Med. 1993;329:1691–1695
  18. Spivak JL. The anaemia of cancer: death by a thousand cuts. Nat Rev Cancer. 2005;5:543–555
  19. Weiss G, Goodnough LT. Anemia of chronic disease. N Engl J Med. 2005;352:1011–1023
  20. Cartwright CE. The anemia of chronic disorders. Sem Hematol. 1966;3:351–375
  21. Means RT, Krantz SB. Progress in understanding the pathogenesis of the anemia of chronic disease. Blood. 1992;80:1639–1647
  22. Burns ER, Goldberg SN, Lawrence C, Wenz B. Clinical utility of serum tests for iron deficiency in hospitalized patients. Am J Clin Pathol. 1990;93:240–245
  23. Jacobs A, Worwood M. Ferritin in serum: clinical and biochemical implications. N Engl J Med. 1975;292:951–956
  24. Guyatt GH, Oxman AD, Ali M, Willan A, McIlroy W, Patterson C. Laboratory diagnosis of iron-deficiency anemia: an overview. J Gen Intern Med. 1992;7:145–153
  25. Coenen JL, van Dieijen-Visser MP, van Pelt J, van Deursen CT, Fickers MM, van Wersch JW, et al. Measurements of serum ferritin used to predict concentrations of iron in bone marrow in anemia of chronic disease. Clin Chem. 1991;37:560–563
  26. Hansen TM, Hansen NE, Birgens HS, Holund B, Lorenzen I. Serum ferritin and the assessment of iron deficiency in rheumatoid arthritis. Scand J Rheumatol. 1983;12:353–359
  27. Witte DL. Can serum ferritin be effectively interpreted in the presence of the acute-phase response?. Clin Chem. 1991;37:484–485
  28. Kurer SB, Seifert B, Michel B, et al. Prediction of iron deficiency in chronic inflammatory rheumatic disease anaemia. Br J Haematol. 1995;91:820–826
  29. Krause JR, Brubaker D, Kaplan S. Comparison of stainable iron in aspirated and needle-biopsy specimens of bone marrow. Am J Clin Pathol. 1979;72:68–70
  30. Punnonen K, Irjala K, Rajamaki A. Serum transferrin receptor and its ratio to serum ferritin in the diagnosis of iron deficiency. Blood. 1997;89:1052–1057
  31. Suominen P, Mottonen T, Rajamaki A, Irjala K. Single values of serum transferrin receptor and transferrin receptor ferritin index can be used to detect true and functional iron deficiency in rheumatoid arthritis patients with anemia. Arthritis Rheum. 2000;43:1016–1020
  32. Guralnik JM, Eisenstaedt RS, Ferrucci L, Klein HG, Woodman RC. The prevalence of anemia in persons age 65 and older in the United States: evidence for a high rate of idiopathic anemia of aging (IAA). Blood. 2003;102:17b
  33. Tilg H, Ulmer H, Kaser A, Weiss G. Role of IL-10 for induction of anemia during inflammation. J Immunol. 2002;169:2204–2209
  34. Faquin WC, Schneider TJ, Goldberg MA. Effect of inflammatory cytokines on hypoxia-induced erythropoietin production. Blood. 1992;79:1987–1994
  35. Nordstrom D, Lindroth Y, Marsal L, Hafstrom I, Henrich C, Rantapaa-Dahlqvist S, et al. Availability of iron and degree of inflammation modifies the response to recombinant human erythropoietin when treating anemia of chronic disease in patients with rheumatoid arthritis. Rheumatol Int. 1997;17:67–73
  36. Weinstein DA, Roy CN, Fleming MD, Loda MF, Wolfsdorf JI, Andrews NC. Inappropriate expression of hepcidin is associated with iron refractory anemia: implications for the anemia of chronic disease. Blood. 2002;100:3776–3781
  37. Roy CN, Weinstein DA, Andrews NC. 2002 E.Mead Johnson Award for Research in Pediatrics Lecture: the molecular biology of the anemia of chronic disease: a hypothesis. Pediatr Res. 2003;53:507–512
  38. Jongen-Lavrencic M, Peeters HR, Wognum A, Vreugdenhil G, Breedveld FC, Swaak AJ. Elevated levels of inflammatory cytokines in bone marrow of patients with rheumatoid arthritis and anemia of chronic disease. J Rheumatol. 1997;24:1504–1509
  39. Papadaki HA, Kritikos HD, Valatas V, Boumpas DT, Eliopoulos GD. Anemia of chronic disease in rheumatoid arthritis is associated with increased apoptosis of bone marrow erythroid cells: improvement following anti-tumor necrosis factor-alpha antibody therapy. Blood. 2002;100:474–482
  40. Silva M, Grillot D, Benito A, Richard C, Nunez G, Fernandez-Luna JL. Erythropoietin can promote erythroid progenitor survival by repressing apoptosis through Bcl-XL and Bcl-2. Blood. 1996;88:1576–1582
  41. Spivak JL. The blood in systemic diseases. Lancet. 2000;355:1707–1712
  42. Baer AN, Dessypris EN, Goldwasser E, Krantz SB. Blunted erythropoietin response to anaemia in rheumatoid arthritis. Br J Haematol. 1987;66:559–564
  43. Miller CB, Jones RJ, Piantadosi S, Abeloff MD, Spivak JL. Decreased erythropoietin response in patients with the anemia of cancer. N Engl J Med. 1990;322:1689–1692
  44. Remacha AF, Rodriguez-de la Serna A, Garcia-Die F, Geli C, Diaz C, Gimferrer E. Erythroid abnormalities in rheumatoid arthritis: the role of erythropoietin. J Rheumatol. 1992;19:1687–1691
  45. Spivak JL, Barnes DC, Fuchs E, Quinn TC. Serum immunoreactive erythropoietin in HIV-infected patients. JAMA. 1989;261:3104–3107
  46. Cazzola M, Mercuriali F, Brugnara C. Use of recombinant human erythropoietin outside the setting of uremia. Blood. 1997;89:4248–4267
  47. Pettersson T, Rosenlof K, Friman C, Mickos A, Teppo AM, Fyhrquist F. Successful treatment of the anemia of rheumatoid arthritis with subcutaneously administered recombinant human erythropoietin. Slower response in patients with more severe inflammation. Scand J Rheumatol. 1993;22:188–193
  48. Pincus T, Olsen NJ, Russell IJ, Wolfe F, Harris ER, Schnitzer TJ, et al. Multicenter study of recombinant human erythropoietin in correction of anemia in rheumatoid arthritis. Am J Med. 1990;89:161–168
  49. Salvarani C, Lasagni D, Casali B, Macchioni P, Boiardi L, Rossi F, et al. Recombinant human erythropoietin therapy in patients with rheumatoid arthritis with the anemia of chronic disease. J Rheumatol. 1991;18:1168–1171
  50. Peeters HR, Jongen-Lavrencic M, Vreugdenhil G, Swaak AJ. Effect of recombinant human erythropoietin on anaemia and disease activity in patients with rheumatoid arthritis and anaemia of chronic disease: a randomised placebo controlled double blind 52 weeks clinical trial. Ann Rheum Dis. 1996;55:739–744
  51. Kurzrock R. The role of cytokines in cancer-related fatigue. Cancer. 2001;92(Suppl 6):1684–1688
  52. Ershler WB. Biological interactions of aging and anemia: a focus on cytokines. J Am Geriatr Soc. 2003;51(Suppl 3):S18–S21
  53. Cooper AC, Mikhail A, Lethbridge MW, Kemeny DM, Macdougall IC. Increased expression of erythropoiesis inhibiting cytokines (IFN-gamma, TNF-alpha, IL-10, and IL-13) by T cells in patients exhibiting a poor response to erythropoietin therapy. J Am Soc Nephrol. 2003;14:1776–1784
  54. Nemeth E, Valore EV, Territo M, Schiller G, Lichtenstein A, Ganz T. Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein. Blood. 2003;101:2461–2463
  55. Ganz T. Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation. Blood. 2003;102:783–788
  56. Pigeon C, Ilyin G, Courselaud B, Leroyer P, Turlin B, Brissot P, et al. A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload. J Biol Chem. 2001;276:7811–7819
  57. Nicolas G, Chauvet C, Viatte L, Danan JL, Bigard X, Devaux I, et al. The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation. J Clin Invest. 2002;110:1037–1044
  58. Nemeth E, Rivera S, Gabayan V, Keller C, Taudorf S, Pedersen BK, et al. IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J Clin Invest. 2004;113:1271–1276
  59. Papanikolaou G, Tzilianos M, Christakis JI, Bogdanos D, Tsimirika K, MacFarlane J, et al. Hepcidin in iron overload disorders. Blood. 2005;105:4103–4105
  60. Krijt J, Vokurka M, Chang KT, Necas E. Expression of Rgmc, the murine ortholog of hemojuvelin gene, is modulated by development and inflammation, but not by iron status or erythropoietin. Blood. 2004;104:4308–4310
  61. Skikne BS, Flowers CH, Cook JD. Serum transferrin receptor: a quantitative measure of tissue iron deficiency. Blood. 1990;75:1870–1876
  62. Pettersson T, Teppo AM, Siimes MA. Circulating transferrin receptor during erythropoietin medication of anemic patients with rheumatoid arthritis. Scand J Rheumatol. 1996;25:321–324
  63. Cook JD. The measurement of serum transferrin receptor. Am J Med Sci. 1999;318:269–276
  64. Patterson C, Turpie ID, Benger AM. Assessment of iron stores in anemic geriatric patients. J Am Geriatr Soc. 1985;33:764–767
  65. Genc S, Erten N, Karan MA, Besisik SK, Saka B, Tascioglu C, et al. Soluble transferrin receptor and soluble transferrin receptor-ferritin index for evaluation of the iron status in elderly patients. Tohoku J Exp Med. 2004;202:135–142
  66. Loria A, Hershko C, Konijn AM. Serum ferritin in an elderly population. J Gerontol. 1979;34:521–524
  67. Kario K, Matsuo T, Nakao K. Serum erythropoietin levels in the elderly. Gerontology. 1991;37:345–348
  68. Carpenter MA, Kendall RG, O’Brien AE, Chapman C, Sebastian JP, Belfield PW, et al. Reduced erythropoietin response to anaemia in elderly patients with normocytic anaemia. Eur J Haematol. 1992;49:119–121
  69. Kario K, Matsuo T, Kodama K, Nakao K, Asada R. Reduced erythropoietin secretion in senile anemia. Am J Hematol. 1992;41:252–257
  70. Nafziger J, Pailla K, Luciani L, Andreux JP, Saint-Jean O, Casadevall N. Decreased erythropoietin responsiveness to iron deficiency anemia in the elderly. Am J Hematol. 1993;43:172–176
  71. Carmel R. Anemia and aging: an overview of clinical, diagnostic and biological issues. Blood Rev. 2001;15:9–18
  72. Leng S, Chaves P, Koenig K, Walston J. Serum interleukin-6 and hemoglobin as physiological correlates in the geriatric syndrome of frailty: a pilot study. J Am Geriatr Soc. 2002;50:1268–1271
  73. Collins AJ, Li S, Gilbertson DT, Liu J, Chen SC, Herzog CA. Chronic kidney disease and cardiovascular disease in the Medicare population. Kidney Int Suppl. 2003;87:S24–S31
  74. McClellan W, Aronoff SL, Bolton WK, Hood S, Lorber DL, Tang KL, et al. The prevalence of anemia in patients with chronic kidney disease. Curr Med Res Opin. 2004;20:1501–1510
  75. De Marchi S, Pirisi M, Ferraccioli GF. Erythropoietin and the anemia of chronic diseases. Clin Exp Rheumatol. 1993;11:429–444
  76. Ble A, Fink JC, Woodman RC, Klausner MA, Windham BG, Guralnik JM, et al. Renal function, erythropoietin and anemia of older persons : the InCHIANTI study. Arch Intern Med. 2005;165:2222–2227
  77. Ferrucci L, Guralnik JM, Woodman RC, Bandinelli S, Lauretani F, Corsi AM, et al. Proinflammatory state and circulating erythropoietin in persons with and without anemia. Am J Med. 2005;118:1288–1296
  78. Balducci L, Hardy CL. Anemia of aging: a model of erythropoiesis in cancer patients. Cancer Control. 1998;5(Suppl 1):17–21
  79. Balducci L. Anemia, cancer, and aging. Cancer Control. 2003;10:478–486
  80. Giuliani N, Sansoni P, Girasole G, Vescovini R, Passeri G, Passeri M, et al. Serum interleukin-6, soluble interleukin-6 receptor and soluble gp130 exhibit different patterns of age- and menopause-related changes. Exp Gerontol. 2001;36:547–557
  81. Ferrucci L, Guralnik JM, Woodman RC, Bandinelli S, Lauretani F, Corsi A, et al. Circulating erythropoietin (EPO) and pro-inflammatory markers in elderly (⩾65) persons with and without anemia. Blood. 2004;104:453a;(abstract 1629)
  82. Ferrucci L, Guralnik JM. Inflammation, hormones, and body composition at a crossroad. Am J Med. 2003;115:501–502
  83. Dharmarajan TS, Avula S, Jayakrishnan L, Joseph P. Mild anemia increases the risk of falls in hospitalized older adults. J Am Geriatr Soc. 2005;53(Suppl 4):S94
  84. Woodman R, Ferrucci L, Guralnik J. Anemia in older adults. Curr Opin Hematol. 2005;12:123–128
  85. Lipschitz D. Medical and functional consequences of anemia in the elderly. J Am Geriatr Soc. 2003;51(Suppl 3):S10–S13
  86. Kikuchi M, Inagaki T, Shinagawa N. Five-year survival of older people with anemia: variation with hemoglobin concentration. J Am Geriatr Soc. 2001;49:1226–1228
  87. Penninx BW, Pahor M, Woodman RC, Ferrucci L, Guralnik JM. Late-life anemia identifies persons at risk for mortality and hospitalization. J Gerontol Med Sci 2006, in press.
  88. Zakai NA, Katz R, Hirsch C, Shlipak MG, Chaves PH, Newman AB, et al. A prospective study of anemia status, hemoglobin concentration, and mortality in an elderly cohort: the Cardiovascular Health Study. Arch Intern Med. 2005;165:2214–2220
  89. Wu WC, Rathore SS, Wang Y, Radford MJ, Krumholz HM. Blood transfusion in elderly patients with acute myocardial infarction. N Engl J Med. 2001;345:1230–1236
  90. Silverberg DS, Wexler D, Iaina A. The role of anemia in the progression of congestive heart failure. Is there a place for erythropoietin and intravenous iron?. J Nephrol. 2004;17:749–761
  91. Sharma R, Francis DP, Pitt B, Poole-Wilson PA, Coats AJ, Anker SD. Haemoglobin predicts survival in patients with chronic heart failure: a substudy of the ELITE II trial. Eur Heart J. 2004;25:1021–1028
  92. Nair D, Shlipak MG, Angeja B, Liu HH, Schiller NB, Whooley MA. Association of anemia with diastolic dysfunction among patients with coronary artery disease in the Heart and Soul Study. Am J Cardiol. 2005;95:332–336
  93. Amin MG, Tighiouart H, Weiner DE, Stark PC, Griffith JL, MacLeod B, et al. Hematocrit and left ventricular mass: the Framingham Heart study. J Am Coll Cardiol. 2004;43:1276–1282
  94. Astor BC, Arnett DK, Brown A, Coresh J. Association of kidney function and hemoglobin with left ventricular morphology among African Americans: the Atherosclerosis Risk in Communities (ARIC) study. Am J Kidney Dis. 2004;43:836–845
  95. Chaves PH, Semba RD, Leng SX, Woodman RC, Ferrucci L, Guralnik JM, et al. Impact of anemia and cardiovascular disease on frailty status of community-dwelling older women: the Women’s Health and Aging Studies I and II. J Gerontol A Biol Sci Med Sci. 2005;60:729–735
  96. Guse CE, Porinsky R. Risk factors associated with hospitalization for unintentional falls: Wisconsin hospital discharge data for patients aged 65 and over. WMJ. 2003;102:37–42
  97. Dharmarajan TS, Norkus EP. Mild anemia and the risk of falls in older adults from nursing homes and the community. J Am Med Dir Assoc. 2004;5:395–400
  98. Duh MS, Lefebvre P, Buteau S, Mody SH, Woodman R. Anemia and risk of accidental falls/fractures in the elderly. J Am Geriatr Soc. 2005;53(Suppl 4):S8–S83
  99. Penninx BW, Pluijm SM, Lips P, Woodman R, Miedema K, Guralnik JM, et al. Late-life anemia is associated with increased risk of recurrent falls. J Am Geriatr Soc. 2005;53:2106–2111
  100. Gruson KI, Aharonoff GB, Egol KA, Zuckerman JD, Koval KJ. The relationship between admission hemoglobin level and outcome after hip fracture. J Orthop Trauma. 2002;16:39–44
  101. Argyriadou S, Vlachonikolis I, Melisopoulou H, Katachanakis K, Lionis C. In what extent anemia coexists with cognitive impairment in elderly: a cross-sectional study in Greece. BMC Fam Pract. 2001;2:5
  102. Chaves PH, Carlson MC, Fried LP. Cognitive function in high functioning older women: does hemoglobin concentration matter. J Am Geriatr Soc. 2002;50(Suppl 4):S149–S150
  103. Zamboni V, Cesari M, Zuccala G, Onder G, Woodman RC, Maraldi C, et al. Anemia and cognitive performance in hospitalized older patients: results from the GIFA study. Int J Geriatr Psychiatry 2006, in press.
  104. Myers E, Grady PO, Dolan AM. The influence of preclinical anaemia on outcome following total hip replacement. Arch Orthop Trauma Surg. 2004;124:699–701
  105. Sabbatini P. The relationship between anemia and quality of life in cancer patients. Oncologist. 2000;5(Suppl 2):19–23
  106. Ross SD, Fahrbach K, Frame D, Scheye R, Connelly JE, Glaspy J. The effect of anemia treatment on selected health-related quality-of-life domains: a systematic review. Clin Ther. 2003;25:1786–1805
  107. Bruunsgaard H. Effects of tumor necrosis factor-alpha and interleukin-6 in elderly populations. Eur Cytokine Netw. 2002;13:389–391
  108. Ferrucci L, Corsi A, Lauretani F, Bandinelli S, Bartali B, Taub DD, et al. The origins of age-related proinflammatory state. Blood. 2005;105:2294–2299
  109. Ershler WB, Keller ET. Age-associated increased interleukin-6 gene expression, late-life diseases, and frailty. Annu Rev Med. 2000;51:245–270
  110. Yaffe K, Lindquist K, Penninx BW, Simonsick EM, Pahor M, Kritchevsky S, et al. Inflammatory markers and cognition in well-functioning African-American and white elders. Neurology. 2003;61:76–80
  111. Papadopoulos NG, Georganas K, Skoutellas V, Konstantellos E, Lyritis GP. Correlation of interleukin-6 serum levels with bone density in postmenopausal women. Clin Rheumatol. 1997;16:162–165
  112. Penninx BW, Guralnik JM, Onder G, Ferrucci L, Wallace RB, Pahor M. Anemia and decline in physical performance among older persons. Am J Med. 2003;115:104–110
  113. Cesari M, Penninx BW, Lauretani F, et al. Hemoglobin levels and skeletal muscle: results from the InCHIANTI study. J Gerontol A Biol Sci Med Sci. 2004;59:249–254
  114. Cesari M, Pahor M, Lauretani F, Penninx BW, Bartali B, Russo R, et al. Bone density and hemoglobin levels in older persons: results from the InCHIANTI study. Osteoporos Int. 2005;16:691–699
  115. Means RT, Olsen NJ, Krantz SB, Dessypris EN, Graber SE, Stone WJ, et al. Treatment of the anemia of rheumatoid arthritis with recombinant human erythropoietin: clinical and in vitro studies. Arthritis Rheum. 1989;32:638–642
  116. Fischl M, Galpin JE, Levine JD, Groopman JE, Henry DH, Kennedy P, et al. Recombinant human erythropoietin for patients with AIDS treated with zidovudine. N Engl J Med. 1990;322:1488–1493
  117. Abels R. Erythropoietin for anaemia in cancer patients. Eur J Cancer. 1993;29A(Suppl 2):S2–S8
  118. Glaspy J, Bukowski R, Steinberg D, Taylor C, Tchekmedyian S, Vadhan-Raj S. Impact of therapy with epoetin alfa on clinical outcomes in patients with nonmyeloid malignancies during cancer chemotherapy in community oncology practice. Procrit Study Group. J Clin Oncol. 1997;15:1218–1234
  119. Schreiber S, Howaldt S, Schnoor M, Nikolaus S, Bauditz J, Gasche C, et al. Recombinant erythropoietin for the treatment of anemia in inflammatory bowel disease. N Engl J Med. 1996;334:619–623
  120. Ershler WB, Artz AS, Kandahari MM. Recombinant erythropoietin treatment of anemia in older adults. J Am Geriatr Soc. 2001;49:1396–1397
  121. Grimley CE, Crouch D, Dolan G. Correction of anaemia of chronic disease (ACD) with small doses of recombinant erythropoietin[abstract]. Br J Haematol. 2003;121(Suppl 1):95
  122. Agnihotri P, Ahuja M, Telfer MC, et al. Chronic anemia and fatigue in elderly patients: results of the first randomized double-blind placebo-controlled cross-over study with epoetin alfa. Blood. 2005;106:Abstract #3553

PII: S0268-960X(05)00070-6

doi: 10.1016/j.blre.2005.12.002

Blood Reviews
Volume 20, Issue 4 , Pages 213-226 , July 2006

Article Tools

* Image Usage & Resolution